[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556943":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":26,"responsibleParty":41,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":5,"acronym":7,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"The Second Affiliated Hospital of Hainan Medical University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","MR-Linac","Radiation therapy with the MR-Linac",[14],{"name":15,"affiliation":5,"role":16},"yuecan zeng, doctor","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"junnv xu, doctor","CONTACT","18208946196","xujunnv@sina.com",{"name":15,"role":20,"phone":24,"phoneExt":7,"email":25},"19946610752","wellyy2005@hainmc.edu.cn",[27],{"facility":5,"status":28,"city":29,"state":7,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Haikou","570311","China","CN",{"type":34,"coordinates":35},"Point",[36,37],110.34651,20.03421,{"lat":37,"lon":36},[40],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100556943","precision-radiotherapy-for-tumours-using-magnetic-resonance-guided-linear-accelerator-mr-linac-100556943",false,"NCT06531681","Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)","Inclusion Criteria:\n\n* Patients are undergoing or have undergone imaging or treatment at the MR linac;\n* Age 18-75 years, male or female;\n* ECOG score 0-2, life expectancy \\> 6 months;\n* Patients provide written informed consent.\n\nExclusion Criteria:\n\n* Contraindications to MRI, such as claustrophobia and metallic or electronic implants incompatible with MRI;\n* The presence of severe comorbidities that, in the opinion of the investigator, · preclude the toleration or completion of radiotherapy;\n* Acute inflammatory disease requiring systemic therapy;\n* The presence of active infectious disease;\n* Pregnant women, nursing mothers, and patients planning to have children during the study period.","ALL","18 Years","75 Years",{"count":53,"type":54},3000,"ESTIMATED","OBSERVATIONAL","Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.",[58,59,60,61],"Overall Response Rate","Oncology","Radiation Toxicity","Quality of Life","2025-02-11",{"date":64,"type":65},"2025-02-13","ACTUAL",{"date":67,"type":65},"2023-08-19",{"date":69,"type":54},"2028-12-31",{"name":5,"class":6},1]